News Contact Us

Cook Medical India moves into new ‘eco-friendly’ office in Chennai

Author : Pankaj Singh | Published Date : 2019-11-04 

Cook Medical India, the India-based subsidiary of Cook Medical, has reportedly shifted its headquarters to a new office in Kocher Jade, Guindy, Chennai.


Sources aware of the development stated that the new 20,000 square feet facility is located in Chennai’s major commercial area with convenient access to air and land transportation services. 


Apparently, the modern, environment-friendly office will offer training facilities with the latest equipment in presentation and video conferencing technology to enable collaborative learning. This, in addition to a high-tech facility, will seemingly help the company enhance its customer service across India. 


Evidently, the design of the new office is focused on increasing the space and environment to enable the use of natural light while reducing carbon footprint. 


According to industry experts, the company’s intention to transform its India-based facility into a new state-of-the-art office and warehouse highlights the significant role the country plays in conducting business for Cook Medical in the Asia-Pacific. 


Cook Medical India General Manager Vijayan Govindaraman stated that driven by the company’s vision to provide solutions rather than sell products, the new logistics office in Chennai will facilitate to enhance its delivery capabilities to clients in major cities across India. 


The office will promote people to work together whereas the new warehouse will ensure quick and efficient systematic distribution of outbound as well as inbound logistics, Govindaraman added


For the record, since 1996, Cook Medical India has provided technical and clinical support to clinicians in India and South Asia through a range of 2,600 products. The company has maintained a steady workforce since its inception and currently has 52 employees. 


Cook Medical had recently collaborated with Italian manufacturer Quanta Systems to deliver state-of-the-art laser technology to clinicians.  


About Cook Medical


Since 1963, Cook Medical has collaborated with clinicians to develop technologies that reduce or eliminate the need for open surgery. Currently, the family-owned company specializes in combining medical devices, biological materials, and cell therapies to help deliver better outcomes for global health care facilities more efficiently.


Source Credits –


About Author

Pankaj Singh

Pankaj Singh

Endowed with a post graduate degree in management and finance, Pankaj Singh has been a part of the online content domain for quite a while. Having worked previously as a U.K. insurance underwriter for two years, he now writes articles for fractovia.org and other online portals. He can be contacted at- [email protected] | https://twitter.com/PankajSingh2605

Related News

The Hop to deploy 35 smart kiosks to support streetcar operations

Published Date: 2020-02-22         Author: Pankaj Singh

The Hop, a modern fixed-transit network, has reportedly collaborated with Smart City Media LLC to execute a smart kiosk transport program that is developed to aid streetcar operations while promoting stronger networks between streetcar routes and key activity centers throughout the central business ... Read More

Qantas warns of a $99Mn financial impact due to coronavirus outbreak

Published Date: 2020-02-21         Author: Pankaj Singh

While most of the coronavirus instances have been observed in China, the global aviation industry is seen to be cautious about the dangerous virus. A new report from Qantas Airways Limited, an Australian airline has put some estimated numbers regarding the financial impacts of the coronavirus, ... Read More

Roche’s Tecentriq bags priority review for treating advanced NSCLC

Published Date: 2020-02-20         Author: Pankaj Singh

Swiss multinational pharmaceutical company, Roche has recently revealed that the U.S. FDA has acknowledged its sBLA (supplemental Biologics License Application) and approved Priority Review for Tecentriq® (atezolizumab) as an initial monotherapy for patients suffering from advanced NSCLC (non-sq... Read More

© 2020 Fractovia. All Rights Reserved